BiotechTube

Micafungin (Mycamine)

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Invasive Candidiasis

Conditions

Invasive Candidiasis, Esophageal Candidiasis, Oropharyngeal Candidiasis, Candidemia

Trial Timeline

Oct 1, 2007 → Oct 1, 2009

NCT ID
NCT00607763

About Micafungin (Mycamine)

Micafungin (Mycamine) is a phase 1 stage product being developed by Astellas Pharma for Invasive Candidiasis. The current trial status is completed. This product is registered under clinical trial identifier NCT00607763. Target conditions include Invasive Candidiasis, Esophageal Candidiasis, Oropharyngeal Candidiasis.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT00607763Phase 1Completed

Competing Products

20 competing products in Invasive Candidiasis

See all competitors
ProductCompanyStageHype Score
BSG005Alkem LaboratoriesPhase 1/2
41
pegylated liposomal doxorubicin (PLD) + PD-1CSPC Pharmaceutical Group LimitedPhase 2
51
Trastuzumab deruxtecan + DurvalumabDaiichi SankyoPhase 2
52
Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
77
Micafungin + fluconazoleAstellas PharmaPhase 3
77
MicafunginAstellas PharmaPre-clinical
23
Pudexacianinium chlorideAstellas PharmaPhase 2
52
Enfortumab vedotin + PembrolizumabAstellas PharmaPhase 2
52
Enfortumab Vedotin + PembrolizumabAstellas PharmaPhase 2
52
Isavuconazonium sulfate + Voriconazole + PosaconazoleAstellas PharmaPre-clinical
23
Pembrolizumab + Enfortumab VedotinAstellas PharmaPhase 3
77
Isavuconazonium sulfate + Isavuconazonium sulfateAstellas PharmaPhase 2
52
Micafungin + Systemic antifungal therapyAstellas PharmaPhase 2
52
MicafunginAstellas PharmaPre-clinical
23
Micafungin + PlaceboAstellas PharmaPhase 3
77
MicafunginAstellas PharmaApproved
85
Olorofim + AmBisome®ShionogiPhase 3
77
Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel + Epirubicin or doxorubicin, cyclophosphamide, paclitaxelJiangsu Hengrui MedicinePhase 3
77
SHR-A1811 + Trastuzumab EmtansineJiangsu Hengrui MedicinePhase 3
77
Herombopag tablets + Herombopag placebo tabletsJiangsu Hengrui MedicinePhase 3
77

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85